61,160,000,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2025-12-31
- Valid until
- still holds
- Published
- 2026-02-20
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "AbbVie revenue: 61,160,000,000 United States dollar", as of 2025-12-31. Claim clm_4A7BE8ED0078, https://asof.is/claim/clm_4A7BE8ED0078, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm.
APA
AsOf. (2025). AbbVie revenue: 61,160,000,000 United States dollar (as of 2025-12-31) [Record clm_4A7BE8ED0078]. Retrieved November 8, 2026, from https://asof.is/claim/clm_4A7BE8ED0078 (source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm)
BibTeX
@misc{asof_clm_4A7BE8ED0078,
author = {AsOf},
title = {AbbVie revenue: 61,160,000,000 United States dollar},
year = {2025},
howpublished = {\url{https://asof.is/claim/clm_4A7BE8ED0078}},
note = {Claim clm\_4A7BE8ED0078, as of 2025-12-31; source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_4A7BE8ED0078.md/v1/claims/clm_4A7BE8ED0078submit a correction